zip health tirzepatide Compounded vs Mounjaro/Zepbound: 75% Cheaper Zepbound® | Zepbound Weight Loss
Description
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes
What works in January may not work in July
A patient with a complicated history benefits from a slower, more thorough setup
Developed by Eli Lilly, Tirzepatide was approved by the US FDA under the brand name Mounjaro, as a first-in-class drug (Chavda et al., 2022)
